Telix Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TELIX, and what generic alternatives to TELIX drugs are available?
TELIX has one approved drug.
There is one US patent protecting TELIX drugs.
There are thirty-nine patent family members on TELIX drugs in eighteen countries.
Drugs and US Patents for Telix
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Telix | ILLUCCIX | gallium ga-68 gozetotide | POWDER;INTRAVENOUS | 214032-001 | Dec 17, 2021 | RX | Yes | Yes | 11,027,031 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Telix Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 112017003578 | ⤷ Sign Up |
Russian Federation | 2017109582 | ⤷ Sign Up |
Japan | 6543343 | ⤷ Sign Up |
European Patent Office | 3862025 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |